Note 8 - Accounts Receivable

3 Months Ended

12 Months Ended

Mar. 31, 2024

Dec. 31, 2023

Accounts Receivable [Member]

Notes to Financial Statements

Accounts and Nontrade Receivable [Text Block]

Note 7. Accounts Receivable

              At March 31, 2024 and December 31, 2023, accounts receivable consisted of the following (in thousands):

	March 31, 2024			December 31, 2023
	(Unaudited)			(Audited)
Gross accounts receivable – trade	$	13,202		$	9,195
Less: allowance for doubtful accounts		(274	)		(272	)
Accounts receivable – trade, net	$	12,928		$	8,923

The Company increased the allowance for credit losses in the amount of approximately $2,000 and $0 for the three months ended March 31, 2024 and 2023, respectively. 

Accounts receivable – trade, net for the Company as of January 1, 2023 and  March 31, 2023 were approximately $0.4 million and $1.0 million, respectively.

Note 8. Accounts Receivable

At December 31, 2023 and 2022, accounts receivable consisted of the following (in thousands):

	Year Ended December 31,
	2023			2022
Gross accounts receivable – trade	$	9,195		$	384
Less: allowance for doubtful accounts		(272	)		—
Accounts receivable – trade, net	$	8,923		$	384

Bad debt expense was approximately $47,000 and $0 for the twelve months ended December 31, 2023 and 2022, respectively.

The increase in accounts receivable was attributable to the consolidation of Progressive Care at July 1, 2023.